The global market for Specialty Enzymes is estimated at US$10.3 Billion in 2023 and is projected to reach US$13.6 Billion by 2030, growing at a CAGR of 4.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the specialty enzymes market is driven by several factors, including increasing demand in pharmaceuticals and biotechnology, technological advancements, and evolving consumer preferences. The rising incidence of chronic diseases and the need for advanced diagnostics and therapies drive demand for specialty enzymes in the healthcare sector. Technological innovations in enzyme engineering and production have improved the specificity, stability, and efficiency of specialty enzymes, making them more effective and cost-efficient for industrial applications.
Consumer demand for high-quality, natural food products is boosting the use of specialty enzymes in the food and beverage industry. Additionally, the emphasis on sustainability and the development of bio-based products propel the market forward, as enzymes play a crucial role in green chemistry and renewable energy production. These drivers highlight the dynamic and evolving nature of the specialty enzymes market, balancing industrial needs with environmental sustainability.
The growth in the specialty enzymes market is driven by several factors, including increasing demand in pharmaceuticals and biotechnology, technological advancements, and evolving consumer preferences. The rising incidence of chronic diseases and the need for advanced diagnostics and therapies drive demand for specialty enzymes in the healthcare sector. Technological innovations in enzyme engineering and production have improved the specificity, stability, and efficiency of specialty enzymes, making them more effective and cost-efficient for industrial applications.
Consumer demand for high-quality, natural food products is boosting the use of specialty enzymes in the food and beverage industry. Additionally, the emphasis on sustainability and the development of bio-based products propel the market forward, as enzymes play a crucial role in green chemistry and renewable energy production. These drivers highlight the dynamic and evolving nature of the specialty enzymes market, balancing industrial needs with environmental sustainability.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Protease segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 3.4%. The Carbohydrases segment is also set to grow at 3.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.8 Billion in 2023, and China, forecasted to grow at an impressive 6.8% CAGR to reach $2.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Specialty Enzymes Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Specialty Enzymes Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Specialty Enzymes Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Advanced Enzymes Technologies Ltd., Amano Enzymes Inc., American Laboratories, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 41 Featured):
- Advanced Enzymes Technologies Ltd.
- Amano Enzymes Inc.
- American Laboratories, Inc.
- Amicogen, Inc.
- BBI Solutions
- Biocatalysts Ltd.
- Codexis, Inc.
- Novozymes A/S
- Roche CustomBiotech
- Thermo Fisher Scientific, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Specialty Enzymes - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Specialty Enzymes Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Protease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Protease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Protease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Carbohydrases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Carbohydrases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Carbohydrases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Polymerases & Nucleases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Lipase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Lipase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Lipase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Research & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Research & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Research & Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
UNITED STATES
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: USA 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
CANADA
- TABLE 38: Canada Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 41: Canada Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: Canada 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
JAPAN
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 44: Japan Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Japan Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Japan 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 47: Japan Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Japan Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Japan 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
CHINA
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 50: China Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: China Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: China 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 53: China Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: China Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: China 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
EUROPE
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 56: Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 57: Europe Historic Review for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Europe 16-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 59: Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: Europe Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: Europe 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 62: Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: Europe Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: Europe 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
FRANCE
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 65: France Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: France Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: France 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 68: France Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: France Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: France 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
GERMANY
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 71: Germany Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Germany Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Germany 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 74: Germany Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Germany Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Germany 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
ITALY
- TABLE 77: Italy Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Italy Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Italy 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 80: Italy Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Italy Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Italy 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 83: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: UK Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: UK 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 86: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: UK Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: UK 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
SPAIN
- TABLE 89: Spain Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Spain Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Spain 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 92: Spain Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Spain Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: Spain 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
- TABLE 95: Russia Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: Russia Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Russia 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 98: Russia Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Russia Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Russia 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Rest of Europe Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Rest of Europe 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Rest of Europe Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: Rest of Europe 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 108: Asia-Pacific Historic Review for Specialty Enzymes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: Asia-Pacific 16-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: Asia-Pacific Historic Review for Specialty Enzymes by Product - Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: Asia-Pacific 16-Year Perspective for Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Protease, Carbohydrases, Polymerases & Nucleases, Lipase and Other Products for the Years 2014, 2024 & 2030
- TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: Asia-Pacific Historic Review for Specialty Enzymes by Application - Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: Asia-Pacific 16-Year Perspective for Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Pharmaceuticals, Research & Biotechnology, Diagnostics and Other Applications for the Years 2014, 2024 & 2030
AUSTRALIA
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
LATIN AMERICA
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned
- Advanced Enzymes Technologies Ltd.
- Amano Enzymes Inc.
- American Laboratories, Inc.
- Amicogen, Inc.
- BBI Solutions
- Biocatalysts Ltd.
- Codexis, Inc.
- Novozymes A/S
- Roche CustomBiotech
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 163 |
Published | December 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 10.3 Billion |
Forecasted Market Value ( USD | $ 13.6 Billion |
Compound Annual Growth Rate | 4.1% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |